Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,009Revenue (TTM) $M2,820Net Margin (%)8.9Altman Z-Score5.9
Enterprise Value $M9,719EPS (TTM) $2.7Operating Margin %12.6Piotroski F-Score8
P/E(ttm)40.5Beneish M-Score-2.8Pre-tax Margin (%)12.7Higher ROA y-yN
Price/Book6.710-y EBITDA Growth Rate %9.8Quick Ratio1.3Cash flow > EarningsY
Price/Sales3.05-y EBITDA Growth Rate %3.8Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow28.2y-y EBITDA Growth Rate %14.4ROA % (ttm)7.4Higher Current Ratio y-yY
Dividend Yield %--PEG7.7ROE % (ttm)16.3Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M91.8ROIC % (ttm)20.6Gross Margin Increase y-yY

Gurus Latest Trades with VAR

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

VAR is held by these investors:



VAR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys. 2017-11-13Sell2,021$107.361.56view
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys. 2017-10-18Sell931$1053.84view
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys. 2017-10-12Sell1,088$101.557.37view
ECKERT R ANDREWDirector 2017-10-06Sell5,651$102.396.49view
WILSON DOW RPresident and CEO 2017-10-06Sell15,059$102.46.47view
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys. 2017-09-13Sell933$107.291.62view
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys. 2017-09-12Sell1,088$107.331.58view
WILSON DOW RPresident and CEO 2017-09-07Sell15,059$105.413.43view
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys. 2017-08-31Sell931$1053.84view
KENNEDY KOLLEEN TEVP and Pres. Oncology Sys. 2017-08-14Sell1,088$97.9111.36view

Quarterly/Annual Reports about VAR:

News about VAR:

Articles On GuruFocus.com
Varian Halcyon Treatment System Receives Shonin Approval Nov 16 2017 
DNAmito Inc. to Integrate Genomics-Based Personalized Analysis With Varian's Oncology Care Managemen Nov 16 2017 
Varian to Showcase Technologies for Enhancing Oncology Care Coordination at AONN+ Conference Nov 14 2017 
Treatments Commence at Two Algerian Hospitals Equipped with Modern Varian Radiotherapy Systems Nov 06 2017 
Varian Selected in Multi-Year Project to Replace Radiotherapy Treatment Equipment at Copenhagen's Ri Nov 03 2017 
Global Availability of Varian Halcyon Treatments Expands with First Cancer Patient Treated in Austra Nov 01 2017 
Varian Names New Chief People Officer, SVP HR Oct 30 2017 
First Patients in US Treated with Varian HyperArc High Definition Radiotherapy Oct 24 2017 
Eye Cancer Patient Treated Using Varian's new HyperArc High Definition Radiotherapy Technology Oct 23 2017 
UZ Leuven Treats First Patient in Europe on Varian Halcyon Cancer Treatment System Oct 17 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK